JP2008501778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501778A5 JP2008501778A5 JP2007526596A JP2007526596A JP2008501778A5 JP 2008501778 A5 JP2008501778 A5 JP 2008501778A5 JP 2007526596 A JP2007526596 A JP 2007526596A JP 2007526596 A JP2007526596 A JP 2007526596A JP 2008501778 A5 JP2008501778 A5 JP 2008501778A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- use according
- symptom
- reboxetine
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000002193 Pain Diseases 0.000 claims 10
- 208000024891 symptom Diseases 0.000 claims 6
- 208000004296 neuralgia Diseases 0.000 claims 4
- 208000021722 neuropathic pain Diseases 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical compound CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 claims 3
- 229960003770 reboxetine Drugs 0.000 claims 3
- CBQGYUDMJHNJBX-OALUTQOASA-N (2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine Chemical compound CCOC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 CBQGYUDMJHNJBX-OALUTQOASA-N 0.000 claims 2
- 206010058019 Cancer Pain Diseases 0.000 claims 2
- 206010065390 Inflammatory pain Diseases 0.000 claims 2
- 208000001294 Nociceptive Pain Diseases 0.000 claims 2
- 208000009935 visceral pain Diseases 0.000 claims 2
- 208000008035 Back Pain Diseases 0.000 claims 1
- 206010016059 Facial pain Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 206010024453 Ligament sprain Diseases 0.000 claims 1
- 208000001738 Nervous System Trauma Diseases 0.000 claims 1
- 206010065016 Post-traumatic pain Diseases 0.000 claims 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010038419 Renal colic Diseases 0.000 claims 1
- 208000010040 Sprains and Strains Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 230000036997 mental performance Effects 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 150000003890 succinate salts Chemical group 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0412878A GB0412878D0 (en) | 2004-06-09 | 2004-06-09 | Use |
| US58865204P | 2004-07-16 | 2004-07-16 | |
| GB0425061A GB0425061D0 (en) | 2004-11-12 | 2004-11-12 | Use |
| US63442704P | 2004-12-07 | 2004-12-07 | |
| PCT/IB2005/001904 WO2006000903A2 (en) | 2004-06-09 | 2005-05-27 | Use of reboxetine for the treatment of pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008501778A JP2008501778A (ja) | 2008-01-24 |
| JP2008501778A5 true JP2008501778A5 (enExample) | 2008-07-10 |
Family
ID=34979099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526596A Withdrawn JP2008501778A (ja) | 2004-06-09 | 2005-05-27 | 疼痛の治療のためのレボキセチンの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080261984A1 (enExample) |
| EP (1) | EP1763354A2 (enExample) |
| JP (1) | JP2008501778A (enExample) |
| KR (1) | KR20070029740A (enExample) |
| AU (1) | AU2005256944A1 (enExample) |
| BR (1) | BRPI0511941A (enExample) |
| CA (1) | CA2567365A1 (enExample) |
| IL (1) | IL178827A0 (enExample) |
| MX (1) | MXPA06014389A (enExample) |
| NO (1) | NO20064642L (enExample) |
| RU (1) | RU2006143659A (enExample) |
| WO (1) | WO2006000903A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090233959A1 (en) | 2008-02-19 | 2009-09-17 | Adolor Corporation | Beloxepin and analogs for the treatment of pain |
| US9320725B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid |
| US20130310385A1 (en) * | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
| US9345689B2 (en) | 2012-05-18 | 2016-05-24 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant |
| US20210177881A1 (en) * | 2018-04-17 | 2021-06-17 | Shanghai Tonglian Pharmaceutical Co., Ltd. | Medicament for preventing and/or treating pain and/or fever, composite product and use thereof |
| WO2019222850A1 (en) * | 2018-05-23 | 2019-11-28 | Wex Pharmaceuticals Inc. | Synergistic tetrodotoxin formulations and methods of treatment for neuropathic pain |
| US20190381056A1 (en) * | 2018-06-17 | 2019-12-19 | Axsome Therapeutics, Inc. | Compositions for delivery of reboxetine |
| WO2019245975A1 (en) * | 2018-06-17 | 2019-12-26 | Axsome Therapeutics, Inc. | Compositions for delivery of reboxetine |
| WO2021113163A1 (en) * | 2019-12-03 | 2021-06-10 | Axsome Therapeutics, Inc. | Use of reboxetine to treat nervous system disorders |
| KR20240119194A (ko) * | 2018-10-15 | 2024-08-06 | 액섬 테라퓨틱스, 인크. | 기면증 치료를 위한 레복세틴의 용도 |
| US11020402B2 (en) | 2018-10-15 | 2021-06-01 | Axsome Therapeutics, Inc. | Use of reboxetine to treat narcolepsy |
| US20200147093A1 (en) | 2018-10-15 | 2020-05-14 | Axsome Therapeutics, Inc. | Use of esreboxetine to treat nervous system disorders such as fibromyalgia |
| US20240415842A1 (en) * | 2019-12-03 | 2024-12-19 | Axsome Therapeutics, Inc. | Use of reboxetine to treat narcolepsy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US422449A (en) * | 1890-03-04 | Gage for gas-cocks | ||
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| EP1500395B1 (en) * | 1999-07-01 | 2006-03-08 | Pharmacia & Upjohn Company LLC | Reboxetine for treating fibromyalgia and other somatoform disorders |
| DE60026704T2 (de) * | 1999-07-01 | 2006-10-19 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetine zur Behandlung chronischer Schmerzen |
| US20040204411A1 (en) * | 2002-12-17 | 2004-10-14 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
| BRPI0413726A (pt) * | 2003-09-09 | 2006-11-07 | Pfizer Prod Inc | combinação de inibidores da recaptação de serotonina e inibidores da recaptação de norepinefrina |
| RU2320369C2 (ru) * | 2003-09-12 | 2008-03-27 | Пфайзер Инк. | Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина |
-
2005
- 2005-05-27 WO PCT/IB2005/001904 patent/WO2006000903A2/en not_active Ceased
- 2005-05-27 KR KR1020067025877A patent/KR20070029740A/ko not_active Ceased
- 2005-05-27 US US11/570,280 patent/US20080261984A1/en not_active Abandoned
- 2005-05-27 RU RU2006143659/152006143659/15A patent/RU2006143659A/ru not_active Application Discontinuation
- 2005-05-27 BR BRPI0511941-3A patent/BRPI0511941A/pt not_active IP Right Cessation
- 2005-05-27 JP JP2007526596A patent/JP2008501778A/ja not_active Withdrawn
- 2005-05-27 AU AU2005256944A patent/AU2005256944A1/en not_active Abandoned
- 2005-05-27 MX MXPA06014389A patent/MXPA06014389A/es not_active Application Discontinuation
- 2005-05-27 CA CA002567365A patent/CA2567365A1/en not_active Abandoned
- 2005-05-27 EP EP05758534A patent/EP1763354A2/en not_active Withdrawn
-
2006
- 2006-10-12 NO NO20064642A patent/NO20064642L/no not_active Application Discontinuation
- 2006-10-23 IL IL178827A patent/IL178827A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501778A5 (enExample) | ||
| EA200900072A1 (ru) | Фенилзамещенные гетероарильные производные и их применение в качестве противоопухолевых средств | |
| JP2008150375A5 (enExample) | ||
| JP2008505054A5 (enExample) | ||
| EA200701175A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
| JP2006528236A5 (enExample) | ||
| JP2013523769A5 (enExample) | ||
| JP2012533565A5 (enExample) | ||
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法 | |
| NO20064642L (no) | Anvendelse av (S,S)- eller racemisk reboxetin | |
| RU2014118448A (ru) | Адсорбенты для перорального введения | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| MY146429A (en) | 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e-]-[1,2,4]-triazolo-[1,5-c-]-pyrimidin-5-amine | |
| DE602007014400D1 (de) | Behandlung pervasiver entwicklungsstörungen | |
| JP2007536279A5 (enExample) | ||
| JP2009516719A5 (enExample) | ||
| JP2009504676A5 (enExample) | ||
| JP2008503445A5 (enExample) | ||
| JP2009526043A5 (enExample) | ||
| RU2007122391A (ru) | S-миртазапин для лечения приливов | |
| JP2006516279A5 (enExample) | ||
| TW200608980A (en) | Use of (s,s)-and racemic reboxetine in the treatment of pain conditions | |
| RU2005104644A (ru) | Способ лечения дисбактериоза кишечника при перитоните | |
| MY138165A (en) | Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome | |
| JP2007230991A5 (enExample) |